Fanous Amy M, Kier Karen L, Rush Michael J, Terrell Sara
Amy M. Fanous, Pharm.D., is Postgraduate Year 1 Pharmacy Resident, ONU HealthWise; Karen L. Kier, Ph.D., B.S.Pharm., BCPS, BCACP, is Professor of Clinical Pharmacy and Director of Assessment; Michael J. Rush, Pharm.D., CDE, BCACP, is Program Director, ONU HealthWise; and Sara Terrell, M.S., CSCS, FMS, is Assistant Professor of Exercise Physiology and Adult Fitness Coordinator, Ohio Northern University, Ada.
Am J Health Syst Pharm. 2014 Jul 15;71(14):1219-25. doi: 10.2146/ajhp130484.
The impact on physical activity and health of a 12-week, pharmacist-directed walking program incorporated into an employee health and wellness clinic was evaluated.
Clinic participants were eligible for study inclusion if they or their spouse was a current or retired employee of Ohio Northern University. Participants received a pedometer, a calendar with specific daily walking goals for the 12-week period, and maps with walking routes. Participants also met with a pharmacist and a student pharmacist for point-of-care tests measuring lipid and fasting glucose concentrations and blood pressure. Participants reported to weekly pedometer checks where steps were recorded and medications were reassessed by the pharmacist or student pharmacist. As an incentive to meet the walking goals, the participants received a raffle ticket each week their goal had been achieved. After 12 weeks, participants reported for a final appointment when all baseline variables were reassessed by a team of health care professionals.
A total of 144 participants were screened at baseline and included in the study, 65 of whom completed the program. At baseline, there were 240 abnormal laboratory test values found in participants with no prior history of dyslipidemia, hyperglycemia, or hypertension. After 12 weeks, significant changes in high-density-lipoprotein (HDL) cholesterol concentrations (p = 0.0012), fasting blood glucose concentrations (p = 0.0017), and blood pressure (p = 0.021) were noted.
A pharmacist-directed walking program that included clinical assessments, walking goals, and weekly pedometer checks was an effective approach to increase employee activity levels, identify previously unknown health conditions, lower blood glucose concentrations and blood pressure values, and increase HDL cholesterol concentrations.
评估纳入员工健康与保健诊所的一项为期12周、由药剂师指导的步行计划对身体活动和健康的影响。
如果诊所参与者本人或其配偶是俄亥俄北方大学的在职或退休员工，则有资格纳入研究。参与者会收到一个计步器、一份包含12周特定每日步行目标的日历以及步行路线图。参与者还会与一名药剂师和一名学生药剂师会面，进行即时检测，测量血脂、空腹血糖浓度和血压。参与者每周报告计步器数据，记录步数，药剂师或学生药剂师会重新评估其用药情况。作为实现步行目标的激励措施，参与者每周达成目标时会获得一张抽奖券。12周后，参与者进行最后一次预约，由一组医疗保健专业人员重新评估所有基线变量。
共有144名参与者在基线时接受筛查并纳入研究，其中65人完成了该计划。基线时，在无血脂异常、高血糖或高血压病史的参与者中发现了240项异常实验室检测值。12周后，观察到高密度脂蛋白（HDL）胆固醇浓度（p = 0.0012）、空腹血糖浓度（p = 0.0017）和血压（p = 0.021）有显著变化。
一项由药剂师指导的步行计划，包括临床评估、步行目标和每周计步器检查，是提高员工活动水平、识别先前未知的健康状况、降低血糖浓度和血压值以及提高HDL胆固醇浓度的有效方法。
